Study identifies new target in treating mesothelioma

July 3, 2012, University of Hawaii at Manoa
July 1, 2012 cover of Cancer Research

(Medical Xpress) -- An international team of researchers, led by Haining Yang, PhD, from the University of Hawai‘i Cancer Center, has identified HMGB1 as a critical protein in the pathogenesis of malignant mesothelioma, one of the most dangerous forms of cancer highly related to asbestos and erionite exposure. The findings are featured as the cover story of the July 1, 2012 issue of Cancer Research, one of the nation's leading cancer research publications.

“We are very excited about this discovery and are extremely pleased that it was also chosen to be the featured cover story,” said Yang. “The next step is to translate this discovery into actual treatments for patients.”

The discovery outlines the process causing the growth of mesothelioma and offers scientists an opportunity to develop specific therapies for treatment. Mesothelioma is an aggressive cancer usually diagnosed at late stages and is resistant to current treatments. The average survival rate is less than one year. However, five percent of patients diagnosed at an early stage have survival rates of five to 10 years or more. The identification of this new biomarker for early detection will help shed light on developing novel targets for mesothelioma prevention and therapy.

Mesothelioma has been linked to occupational and environmental exposure to asbestos. Erionite, a naturally occurring mineral fiber, also causes mesothelioma. In the United States, approximately 3,000 cases of mesothelioma are diagnosed each year. It has been estimated that over 25 million people have been exposed to asbestos in the U.S., while the amount of those exposed to erionite is unknown.

The UH Cancer Center is a global leader in mesothelioma research. The center’s thoracic oncology team led by Director Michele Carbone, MD, PhD, and Yang, has also been instrumental in several other recent discoveries including the identification of the gene that causes mesothelioma, BAP1.

The current study was an international effort and included investigators from the University of Hawai‘i Cancer Center, the John A Burns School of Medicine in Honolulu, the San Raffaele University and Research Institute in Milan, Italy, the National Institutes of Health in Bethesda, Md., and the New York University School of Medicine.

Explore further: Scientists find genetic link to mesothelioma

Related Stories

Scientists find genetic link to mesothelioma

August 28, 2011
Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer – mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed ...

New study finds cancer-causing mineral in US road gravel

July 25, 2011
As school buses drive down the gravel roads in Dunn County, North Dakota, they stir up more than dirt. The clouds of dust left in their wake contain such high levels of the mineral erionite that those who breathe in the air ...

Renal cancer drug temsirolimus shows promise against mesothelioma

May 1, 2011
A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

Photodynamic therapy added to lung-sparing surgery improves survival for mesothelioma patients

May 30, 2012
(Medical Xpress) -- Among patients with malignant pleural mesothelioma, treatment with lung-sparing surgery in combination with photodynamic therapy (PDT) yielded unusually long survival rates, with median survival rates ...

Recommended for you

Cancer comes back all jacked up on stem cells

March 19, 2018
After a biopsy or surgery, doctors often get a molecular snapshot of a patient's tumor. This snapshot is important - knowing the genetics that cause a cancer can help match a patient with a genetically-targeted treatment. ...

A small, daily dose of Viagra may reduce colorectal cancer risk

March 19, 2018
A small, daily dose of Viagra significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the third leading cause of cancer death, scientists report.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.

Improved capture of cancer cells in blood could help track disease

March 15, 2018
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer - even though most free-floating cancer cells will not go on to establish a new tumor.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.